Attenuation of myocardial ischemia-reperfusion injury with nitric oxide replacement therapy.
about
Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protectionMyocardial protection during cardiac surgery from the viewpoint of coronary endothelial function.Sulfaphenazole protects heart against ischemia-reperfusion injury and cardiac dysfunction by overexpression of iNOS, leading to enhancement of nitric oxide bioavailability and tissue oxygenation.Protection of coronary endothelial function during cardiac surgery: potential of targeting endothelial ion channels in cardioprotectionThe role of nitric oxide, superoxide and peroxynitrite in the anti-arrhythmic effects of preconditioning and peroxynitrite infusion in anaesthetized dogsCardioprotective effects of nitrite during exercise.Free radicals, diabetes and endothelial dysfunction.The nitric oxide donor S-nitroso-N-acetylpenicillamine (SNAP) increases free radical generation and degrades left ventricular function after myocardial ischemia-reperfusion.Role of adenosine as adjunctive therapy in acute myocardial infarction.Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury.Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury.Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failureEndothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite.Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protective.Trans-system mechanisms against ischemic myocardial injury.New developments in nitrosovasodilator therapy.Deficiency in myocardial NO biosignalling after cardioplegic arrest: mechanisms and contribution to post-storage mechanical dysfunction.No effect of L-arginine supplementation on pulmonary endothelial dysfunction after cardiopulmonary bypass.O2(-)-mediated impairment of coronary arterial relaxation is prevented by overnight treatment with 1 nM beta-estradiol.Metformin improves cardiac function in rats via activation of AMP-activated protein kinase.
P2860
Q26751288-012BDDEF-0569-47B7-B301-5000FA5411B4Q33767301-73158782-FFF1-4DF7-A481-A9747A1212F8Q33772589-1BC43F47-F5C7-40E6-8B4F-9145439997BBQ34003211-B6F10C96-096B-4520-B777-5C5854BC93E8Q34113039-EA8ECF17-D138-40EE-B243-C422C85404C5Q34530202-CF079D8A-F889-4886-AEEC-24A8DE027B1BQ34722600-248CD47E-4384-4261-8955-AC4152DE16F4Q35129243-36C1F70F-9C50-413C-AF07-14A49E6E0765Q36589382-A2E192A3-20E9-458A-B80A-DB84F5C1F976Q36750685-239D5424-2706-48EE-99F7-1FE442ABDA9AQ37252148-2C7C4AD9-826B-485C-9B8A-B99AB24B1283Q37259538-C3B7DAC2-81D7-4611-836D-D08F07174419Q37370840-21D78F43-AEB8-4A49-92CF-5045717D8D68Q37477176-4A17A3E3-613A-454B-8EA5-7E83979D06DEQ38318626-F9DB681A-BEBF-4297-A76A-6701AA10DEF1Q41740454-AC97D166-30C9-4A39-9FFD-8083C78CC2E8Q43260847-F1552F20-E773-4A10-959F-230F9219BCC6Q43573455-0CB0AF87-3857-4FB7-8751-60E7B54E7199Q44187534-BE79E295-09D1-41FF-86FC-711241686E64Q54398245-135D31C2-8110-480B-B4BA-78D4A526161B
P2860
Attenuation of myocardial ischemia-reperfusion injury with nitric oxide replacement therapy.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Attenuation of myocardial isch ...... ric oxide replacement therapy.
@en
type
label
Attenuation of myocardial isch ...... ric oxide replacement therapy.
@en
prefLabel
Attenuation of myocardial isch ...... ric oxide replacement therapy.
@en
P1476
Attenuation of myocardial isch ...... ric oxide replacement therapy.
@en
P2093
P304
P356
10.1016/0003-4975(95)00423-I
P407
P577
1995-09-01T00:00:00Z